Qun Guan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Qun Guan has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Yu-Bin Dong
College of Chemistry, Chemical Engineering and Materials Science, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Key Laboratory of Molecular and Nano Probes, Ministry of Education
31 shared publications - Yan-An Li
College of Chemistry, Chemical Engineering and Materials Science, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Shandong Normal University, Jinan 250014, P. R. China
17 shared publications Le-Le Zhou
University of Macau
16 shared publicationsWen-Yan Li
College of Chemistry, Chemical Engineering and Materials Science, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Shandong Normal University, Jinan 250014, P. R. China
11 shared publicationsLe‐Le Zhou
State Key Laboratory of Mechanism and Quality of Chinese Medicine Institute of Chinese Medical Sciences University of Macau Taipa Macao China
8 shared publicationsJing-Lan Kan
College of Chemistry, Chemical Engineering and Materials Science, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Shandong Normal University, Jinan, 250014, P. R. China
6 shared publications
Latest Publications
- Open Access
- 24 July 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (30) , 31634-31640
Spontaneous Intracellular Formation of Covalent Organic Frameworks via Enzyme-Initiated Cascade Reactions to Boost Cancer Radiotherapy
Tumor radioresistance is a leading cause of radiotherapy failure. This study presents a facile strategy for enhancing tumor radiosensitivity using a covalent organic framework (COF) constructed within cells. Upon cellular internalization, acetamide and iodoacetal precursors undergo hydrolysis to form amine and iodoaldehyde monomers that spontaneously polymerize and crystallize within the lysosomes. This intracellularly generated iodine-rich COF (in situ UM-113) possesses an ordered structure that effectively facilitates radiation energy deposition, producing localized reactive oxygen species and amplifying DNA damage. In vitro and in vivo, in situ UM-113 suppresses tumor growth by triggering both ferroptosis and mitotic catastrophe. This strategy bypasses the complex synthesis and purification steps required for conventional nanomedicine. Thus, in situ COF construction is a promising strategy for enhancing cancer radiotherapy, offering a modular platform for the intracellular synthesis of functional bionanomaterials.
- 24 July 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (30) , 31634-31640
Open AccessSpontaneous Intracellular Formation of Covalent Organic Frameworks via Enzyme-Initiated Cascade Reactions to Boost Cancer Radiotherapy
Tumor radioresistance is a leading cause of radiotherapy failure. This study presents a facile strategy for enhancing tumor radiosensitivity using a covalent organic framework (COF) constructed within cells. Upon cellular internalization, acetamide and iodoacetal precursors undergo hydrolysis to form amine and iodoaldehyde monomers that spontaneously polymerize and crystallize within the lysosomes. This intracellularly generated iodine-rich COF (in situ UM-113) possesses an ordered structure that effectively facilitates radiation energy deposition, producing localized reactive oxygen species and amplifying DNA damage. In vitro and in vivo, in situ UM-113 suppresses tumor growth by triggering both ferroptosis and mitotic catastrophe. This strategy bypasses the complex synthesis and purification steps required for conventional nanomedicine. Thus, in situ COF construction is a promising strategy for enhancing cancer radiotherapy, offering a modular platform for the intracellular synthesis of functional bionanomaterials.
- Open Access
- 17 February 2026
- Published by Wiley in Advanced Materials
- Vol. 38 (16) , e10663
In Situ Synthesis of Covalent Organic Frameworks Inside Cells for Triggering Ferroptosis and Immunotherapy
The synthesis of non‐natural polymers inside living systems has become an effective approach for controlling cellular functions and behaviors. However, in situ synthesis of crystalline polymers, such as covalent organic frameworks (COFs), inside cells using dynamic covalent chemistry faces challenges in aqueous environments, crystallization, and functionality. Herein, we present an intralysosomal crystalline polymerization strategy to synthesize COFs inside tumor cells through an acid‐catalyzed imine condensation reaction. The COFs synthesized intracellularly exhibit inherent fluorescence and well‐defined crystalline structures, allowing real‐time monitoring of the synthesis and product characterization. The formation of imine frameworks inside cell lysosomes induces lysosomal damage, activates lysosomal iron, and triggers immunogenic ferroptosis, thus enhancing antitumor immunotherapy. This strategy of intralysosomal crystalline polymerization facilitates the ambient synthesis of COFs, opening avenues for therapeutic polymerization reactions and providing insights into cellular responses to in situ polymer synthesis.
- 17 February 2026
- Published by Wiley in Advanced Materials
- Vol. 38 (16) , e10663
Open AccessIn Situ Synthesis of Covalent Organic Frameworks Inside Cells for Triggering Ferroptosis and Immunotherapy
The synthesis of non‐natural polymers inside living systems has become an effective approach for controlling cellular functions and behaviors. However, in situ synthesis of crystalline polymers, such as covalent organic frameworks (COFs), inside cells using dynamic covalent chemistry faces challenges in aqueous environments, crystallization, and functionality. Herein, we present an intralysosomal crystalline polymerization strategy to synthesize COFs inside tumor cells through an acid‐catalyzed imine condensation reaction. The COFs synthesized intracellularly exhibit inherent fluorescence and well‐defined crystalline structures, allowing real‐time monitoring of the synthesis and product characterization. The formation of imine frameworks inside cell lysosomes induces lysosomal damage, activates lysosomal iron, and triggers immunogenic ferroptosis, thus enhancing antitumor immunotherapy. This strategy of intralysosomal crystalline polymerization facilitates the ambient synthesis of COFs, opening avenues for therapeutic polymerization reactions and providing insights into cellular responses to in situ polymer synthesis.
- Open Access
- 22 January 2025
- Published by Wiley in Angewandte Chemie
- Vol. 137 (8)
An sp2 Carbon‐Conjugated Covalent Organic Framework for Fusing Lipid Droplets and Engineered Macrophage Therapy
Engineered immune cell therapy has proven to be a transformative cancer treatment despite the challenges of its prohibitive costs and manufacturing complexity. In this study, we propose a concise “lipid droplet fusion” strategy for engineering macrophages. Because of the integration of hydrophobic alkyl chains and π‐conjugated structures, the mildly synthesized sp2C‐conjugated covalent organic framework (COF) UM‐101 induced lipid droplet fusion and metabolic reprogramming of macrophages, thus promoting their antitumor classical activation. Intravenous injection of UM‐101–engineered macrophages effectively inhibited tumor progression. These results represent the first report of room‐temperature synthesis of sp2C‐conjugated COFs for engineered immune cell therapy, providing a new perspective for the development of therapeutic immune cells via organelle manipulation.
- 22 January 2025
- Published by Wiley in Angewandte Chemie
- Vol. 137 (8)
Open AccessAn sp2 Carbon‐Conjugated Covalent Organic Framework for Fusing Lipid Droplets and Engineered Macrophage Therapy
Engineered immune cell therapy has proven to be a transformative cancer treatment despite the challenges of its prohibitive costs and manufacturing complexity. In this study, we propose a concise “lipid droplet fusion” strategy for engineering macrophages. Because of the integration of hydrophobic alkyl chains and π‐conjugated structures, the mildly synthesized sp2C‐conjugated covalent organic framework (COF) UM‐101 induced lipid droplet fusion and metabolic reprogramming of macrophages, thus promoting their antitumor classical activation. Intravenous injection of UM‐101–engineered macrophages effectively inhibited tumor progression. These results represent the first report of room‐temperature synthesis of sp2C‐conjugated COFs for engineered immune cell therapy, providing a new perspective for the development of therapeutic immune cells via organelle manipulation.
- Open Access
- 22 January 2025
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 64 (8) , e202421416
An sp2 Carbon‐Conjugated Covalent Organic Framework for Fusing Lipid Droplets and Engineered Macrophage Therapy
Engineered immune cell therapy has proven to be a transformative cancer treatment despite the challenges of its prohibitive costs and manufacturing complexity. In this study, we propose a concise “lipid droplet fusion” strategy for engineering macrophages. Because of the integration of hydrophobic alkyl chains and π‐conjugated structures, the mildly synthesized sp2C‐conjugated covalent organic framework (COF) UM‐101 induced lipid droplet fusion and metabolic reprogramming of macrophages, thus promoting their antitumor classical activation. Intravenous injection of UM‐101–engineered macrophages effectively inhibited tumor progression. These results represent the first report of room‐temperature synthesis of sp2C‐conjugated COFs for engineered immune cell therapy, providing a new perspective for the development of therapeutic immune cells via organelle manipulation.
- 22 January 2025
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 64 (8) , e202421416
Open AccessAn sp2 Carbon‐Conjugated Covalent Organic Framework for Fusing Lipid Droplets and Engineered Macrophage Therapy
Engineered immune cell therapy has proven to be a transformative cancer treatment despite the challenges of its prohibitive costs and manufacturing complexity. In this study, we propose a concise “lipid droplet fusion” strategy for engineering macrophages. Because of the integration of hydrophobic alkyl chains and π‐conjugated structures, the mildly synthesized sp2C‐conjugated covalent organic framework (COF) UM‐101 induced lipid droplet fusion and metabolic reprogramming of macrophages, thus promoting their antitumor classical activation. Intravenous injection of UM‐101–engineered macrophages effectively inhibited tumor progression. These results represent the first report of room‐temperature synthesis of sp2C‐conjugated COFs for engineered immune cell therapy, providing a new perspective for the development of therapeutic immune cells via organelle manipulation.
- 1 January 2025
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 13 (19) , 5382-5389
MOF-based nanoagent for self-illuminating photodynamic therapy
A MOF-based self-illuminating system, which can be a highly efficient photodynamic therapy nanoagent for tumor treatment without an external light source, is reported.
- 1 January 2025
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 13 (19) , 5382-5389
MOF-based nanoagent for self-illuminating photodynamic therapy
A MOF-based self-illuminating system, which can be a highly efficient photodynamic therapy nanoagent for tumor treatment without an external light source, is reported.
- 29 November 2023
- Published by Wiley in Angewandte Chemie
- Vol. 136 (8)
Covalent Organic Frameworks: Opportunities for Rational Materials Design in Cancer Therapy
Nanomedicines are extensively used in cancer therapy. Covalent organic frameworks (COFs) are crystalline organic porous materials with several benefits for cancer therapy, including porosity, design flexibility, functionalizability, and biocompatibility. This review examines the use of COFs in cancer therapy from the perspective of reticular chemistry and function‐oriented materials design. First, the modification sites and functionalization methods of COFs are discussed, followed by their potential as multifunctional nanoplatforms for tumor targeting, imaging, and therapy by integrating functional components. Finally, some challenges in the clinical translation of COFs are presented with the hope of promoting the development of COF‐based anticancer nanomedicines and bringing COFs closer to clinical trials.
- 29 November 2023
- Published by Wiley in Angewandte Chemie
- Vol. 136 (8)
Covalent Organic Frameworks: Opportunities for Rational Materials Design in Cancer Therapy
Nanomedicines are extensively used in cancer therapy. Covalent organic frameworks (COFs) are crystalline organic porous materials with several benefits for cancer therapy, including porosity, design flexibility, functionalizability, and biocompatibility. This review examines the use of COFs in cancer therapy from the perspective of reticular chemistry and function‐oriented materials design. First, the modification sites and functionalization methods of COFs are discussed, followed by their potential as multifunctional nanoplatforms for tumor targeting, imaging, and therapy by integrating functional components. Finally, some challenges in the clinical translation of COFs are presented with the hope of promoting the development of COF‐based anticancer nanomedicines and bringing COFs closer to clinical trials.
- 29 November 2023
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 63 (8) , e202314763
Covalent Organic Frameworks: Opportunities for Rational Materials Design in Cancer Therapy
Nanomedicines are extensively used in cancer therapy. Covalent organic frameworks (COFs) are crystalline organic porous materials with several benefits for cancer therapy, including porosity, design flexibility, functionalizability, and biocompatibility. This review examines the use of COFs in cancer therapy from the perspective of reticular chemistry and function‐oriented materials design. First, the modification sites and functionalization methods of COFs are discussed, followed by their potential as multifunctional nanoplatforms for tumor targeting, imaging, and therapy by integrating functional components. Finally, some challenges in the clinical translation of COFs are presented with the hope of promoting the development of COF‐based anticancer nanomedicines and bringing COFs closer to clinical trials.
- 29 November 2023
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 63 (8) , e202314763
Covalent Organic Frameworks: Opportunities for Rational Materials Design in Cancer Therapy
Nanomedicines are extensively used in cancer therapy. Covalent organic frameworks (COFs) are crystalline organic porous materials with several benefits for cancer therapy, including porosity, design flexibility, functionalizability, and biocompatibility. This review examines the use of COFs in cancer therapy from the perspective of reticular chemistry and function‐oriented materials design. First, the modification sites and functionalization methods of COFs are discussed, followed by their potential as multifunctional nanoplatforms for tumor targeting, imaging, and therapy by integrating functional components. Finally, some challenges in the clinical translation of COFs are presented with the hope of promoting the development of COF‐based anticancer nanomedicines and bringing COFs closer to clinical trials.
- 6 October 2023
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 17 (20) , 20445-20461
A Multifunctional Covalent Organic Framework Nanozyme for Promoting Ferroptotic Radiotherapy against Esophageal Cancer
Radiotherapy is inevitably accompanied by some degree of radiation resistance, which leads to local recurrence and even therapeutic failure. To overcome this limitation, herein, we report the room-temperature synthesis of an iodine- and ferrocene-loaded covalent organic framework (COF) nanozyme, termed TADI-COF-Fc, for the enhancement of radiotherapeutic efficacy in the treatment of radioresistant esophageal cancer. The iodine atoms on the COF framework not only exerted a direct effect on radiotherapy, increasing its efficacy by increasing X-ray absorption, but also promoted the radiolysis of water, which increased the production of reactive oxygen species (ROS). In addition, the ferrocene surface decoration disrupted redox homeostasis by increasing the levels of hydroxyl and lipid peroxide radicals and depleting intracellular antioxidants. Both in vitro and in vivo experiments substantiated the excellent radiotherapeutic response of TADI-COF-Fc. This study demonstrates the potential of COF-based multinanozymes as radiosensitizers and suggests a possible treatment integration strategy for combination oncotherapy.
- 6 October 2023
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 17 (20) , 20445-20461
A Multifunctional Covalent Organic Framework Nanozyme for Promoting Ferroptotic Radiotherapy against Esophageal Cancer
Radiotherapy is inevitably accompanied by some degree of radiation resistance, which leads to local recurrence and even therapeutic failure. To overcome this limitation, herein, we report the room-temperature synthesis of an iodine- and ferrocene-loaded covalent organic framework (COF) nanozyme, termed TADI-COF-Fc, for the enhancement of radiotherapeutic efficacy in the treatment of radioresistant esophageal cancer. The iodine atoms on the COF framework not only exerted a direct effect on radiotherapy, increasing its efficacy by increasing X-ray absorption, but also promoted the radiolysis of water, which increased the production of reactive oxygen species (ROS). In addition, the ferrocene surface decoration disrupted redox homeostasis by increasing the levels of hydroxyl and lipid peroxide radicals and depleting intracellular antioxidants. Both in vitro and in vivo experiments substantiated the excellent radiotherapeutic response of TADI-COF-Fc. This study demonstrates the potential of COF-based multinanozymes as radiosensitizers and suggests a possible treatment integration strategy for combination oncotherapy.
- 22 May 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 59 (48) , 7463-7466
A covalent organic framework-based nanoreactor for enhanced photothermal therapy via inhibiting intracellular heat defense systems
Herein, we report an indocyanine green (ICG)-decorated and glucose oxidase (GOx)-loaded nanoscale composite COF material via a stepwise post-synthetic modification. The obtained GOx@COF-ICG can achieve synergistic inhibition of intracellular heat defense systems through starvation therapy to enhance photothermal therapy of tumors.
- 22 May 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 59 (48) , 7463-7466
A covalent organic framework-based nanoreactor for enhanced photothermal therapy via inhibiting intracellular heat defense systems
Herein, we report an indocyanine green (ICG)-decorated and glucose oxidase (GOx)-loaded nanoscale composite COF material via a stepwise post-synthetic modification. The obtained GOx@COF-ICG can achieve synergistic inhibition of intracellular heat defense systems through starvation therapy to enhance photothermal therapy of tumors.
- 12 April 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 59 (36) , 5423-5426
A reactive oxygen species-responsive covalent organic framework for tumor combination therapy
Herein, we report the first reactive oxygen species (ROS)-responsive dithioketal-linked covalent organic framework (COF) for synergetic chemotherapy and photodynamic therapy (PDT) of cancer. The singlet oxygen (1O2)-responsive COF dissociation and DC_AC50 drug release complement and reinforce each other to allow an efficient combination of PDT and chemotherapy.
- 12 April 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 59 (36) , 5423-5426
A reactive oxygen species-responsive covalent organic framework for tumor combination therapy
Herein, we report the first reactive oxygen species (ROS)-responsive dithioketal-linked covalent organic framework (COF) for synergetic chemotherapy and photodynamic therapy (PDT) of cancer. The singlet oxygen (1O2)-responsive COF dissociation and DC_AC50 drug release complement and reinforce each other to allow an efficient combination of PDT and chemotherapy.